The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study
Clinical trial NCT05873309 · COMPLETED
Trial details
- NCT number
- NCT05873309
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-26
- Primary completion
- 2024-09-23
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.